Baseline characteristics, disease activity, patient-reported outcomes (PROs) and safety in 465 patients with rheumatoid arthritis (RA) treated with filgotinib in Germany: Up to 18-month interim results from FILOSOPHY

Introduction: A prospective, observational study (FILOSOPHY; NCT04871919) of filgotinib, a preferential Janus kinase 1 inhibitor for the treatment of RA, in a real-world setting is ongoing in Europe. We aimed to assess baseline characteristics, effectiveness, PROs and safety data for patients treated [for full text, please go to the a.m. URL]

Institutions

Publication Details

Journal
German Medical Science (German Research Foundation)
Published
2024-09-18
DOI
https://doi.org/10.3205/24dgrh154
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baseline characteristics, disease activity, patient-reported outcomes (PROs) and safety in 465 patients with rheumatoid arthritis (RA) treated with filgotinib in Germany: Up to 18-month interim results from FILOSOPHY

German Medical Science (German Research Foundation)
Rheumatoid Arthritis Research and Therapies
article

Baseline characteristics, disease activity, patient-reported outcomes (PROs) and safety in 465 patients with rheumatoid arthritis (RA) treated with filgotinib in Germany: Up to 18-month interim results from FILOSOPHY

article en

Abstract

Introduction: A prospective, observational study (FILOSOPHY; NCT04871919) of filgotinib, a preferential Janus kinase 1 inhibitor for the treatment of RA, in a real-world setting is ongoing in Europe. We aimed to assess baseline characteristics, effectiveness, PROs and safety data for patients treated [for full text, please go to the a.m. URL]

German Medical Science (German Research Foundation)
Universität Greifswald (DE), Rheumazentrum Ruhrgebiet (DE), Klinikum Magdeburg (DE), Neubrandenburg University of Applied Sciences (DE), University Hospital Magdeburg (DE), Charité - Universitätsmedizin Berlin (DE), Galapagos (Belgium) (BE), Ruhr University Bochum (DE)
Good health and well-being
Openalex Percentile: Top 54%
Rheumatoid Arthritis Research and Therapies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.